Chinese Journal of Pharmacovigilance ›› 2014, Vol. 11 ›› Issue (12): 743-745.

Previous Articles     Next Articles

Exploration on the Model of Cosmetic Adverse Reactions Monitoring in China

LU Chang-fei1, SHEN Lu2, TIAN Yue-jie1, ZHOU Zhi-jun1, LI Xin-ling2, CHENG Gang2, DU Xiao-xi2, *   

  1. 1Shandong Centre for ADR Monitoring, Shandong Jinan 250013, China; 2Centre for Drug Reevaluation, CFDA, Beijing 100045, China
  • Received:2014-02-13 Revised:2016-02-03 Online:2014-12-08 Published:2016-03-02

Abstract: This article aimed to establish and explore the model of cosmetic adverse reaction monitoring based on the models of MOH's cosmetic adverse reaction monitoring and adverse drug reactions monitoring at the new stage governed by CFDA. The preliminary model established for primary stage was composed of national, provincial 2 level institutions and cosmetic adverse reaction monitoring sentinels. All of the cosmetic adverse reactions monitoring agencies receive diagnostic reports with the clear causal relationship between the products and the reactions. The model has many advantages and may be suitable for China.

Key words: cosmetic adverse reaction, monitor, model

CLC Number: